Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with FDA Removes 12 Peptides from Restricted List: What It Means TikTok FDA Moves to Reevaluate Several Peptides American Med Spa Association